← Evidence map

ReviewEuropean journal of pharmacology2002

The discovery and status of sibutramine as an anti-obesity drug.

Carla A Luque et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2002
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT00941382phase 360 enrolled2008
Full record →Abstract, authors, funding and every citing paper · PMID 12007530